Premium
Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development
Author(s) -
Kirsten N.,
Bulai Livideanu C.,
Richard M.A.,
Konstantinou M.P.,
Khemis A.,
Balluteaud C.,
Goujon C.,
BeylotBarry M.,
Paul C.
Publication year - 2016
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.14622
Subject(s) - psoriasis , drug , medicine , inclusion (mineral) , inclusion and exclusion criteria , drug development , phase (matter) , intensive care medicine , clinical trial , pharmacology , dermatology , alternative medicine , psychology , pathology , chemistry , social psychology , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom